Market Value3,619,767,000
Total Holdings94
File Date2021-05-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCAB / BioAtla, Inc.
AVTR / Avantor, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ANIK / Anika Therapeutics, Inc.
BVS / Bioventus Inc.
ABMD / Abiomed Inc.
CRIS / Curis, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
AFMD / Affimed N.V.
IMAB / I-Mab - Depositary Receipt (Common Stock)
NUVB / Nuvation Bio Inc.
AMWL / American Well Corporation
ANNX / Annexon, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
CAH / Cardinal Health, Inc.
EXAS / Exact Sciences Corporation
ZNTL / Zentalis Pharmaceuticals, Inc.
BTAI / BioXcel Therapeutics, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
ORGO / Organogenesis Holdings Inc.
STRO / Sutro Biopharma, Inc.
CMRX / Chimerix, Inc.
CMIIU / CM Life Sciences II Inc - Units (1 Ord Share Class A & 1/5 War)
BMRN / BioMarin Pharmaceutical Inc.
RLAY / Relay Therapeutics, Inc.
HMIN / Homeinns Hotel Group
CHNG / Change Healthcare Inc
NRIX / Nurix Therapeutics, Inc.
OSH / Oak Street Health Inc
INZY / Inozyme Pharma, Inc.
ITOS / iTeos Therapeutics, Inc.
OM / Outset Medical, Inc.
LGND / Ligand Pharmaceuticals Incorporated
TSHA / Taysha Gene Therapies, Inc.
MRTX / Mirati Therapeutics, Inc.
COLL / Collegium Pharmaceutical, Inc.
SMFR / Sema4 Holdings Corp - Class A
/ Vesper Healthcare Acquisition Corp. Unit
XLRN / Acceleron Pharma Inc
INO / Inovio Pharmaceuticals, Inc.
MRUS / Merus N.V.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
IGMS / IGM Biosciences, Inc.
ATHA / Athira Pharma, Inc.
ATRC / AtriCure, Inc.
CERT / Certara, Inc.
CDXS / Codexis, Inc.
KURA / Kura Oncology, Inc.
STTK / Shattuck Labs, Inc.
ZYME / Zymeworks Inc.
CSTL / Castle Biosciences, Inc.
ALBO / Albireo Pharma Inc
SGTX / Sigilon Therapeutics Inc
RETA / Reata Pharmaceuticals Inc - Class A
ADMS / Adamas Pharmaceuticals Inc
PHVS / Pharvaris N.V.
IMTX / Immatics N.V.
ARYD / ARYA Sciences Acquisition Corp IV
EVLO / Evelo Biosciences, Inc.
KYG5960S1167 / Medicus Sciences Acquisition Corp. Unit
TNGX / Tango Therapeutics, Inc.
DGX / Quest Diagnostics Incorporated
CCXI / ChemoCentryx Inc
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
TRIL / Trillium Therapeutics Inc
HCAQ / HealthCor Catalio Acquisition Corp - Class A
HARP / Harpoon Therapeutics, Inc.
LSAQ / LifeSci Acquisition II Corp
TIL / Instil Bio, Inc.
SHC / Sotera Health Company
ARNA / Arena Pharmaceuticals Inc
ZBH / Zimmer Biomet Holdings, Inc.
ALDX / Aldeyra Therapeutics, Inc.
DVAX / Dynavax Technologies Corporation
OCUL / Ocular Therapeutix, Inc.
US33830X1046 / Five Prime Therapeutics Inc
PHAS / PhaseBio Pharmaceuticals Inc
HZNP / Horizon Therapeutics Plc
BOLT / Bolt Biotherapeutics, Inc.
MDT / Medtronic plc
BLU / Bellus Health Inc
ACAD / ACADIA Pharmaceuticals Inc.
CRDF / Cardiff Oncology, Inc.
BIIB / Biogen Inc. Call
NAUT / Nautilus Biotechnology, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
KDMN / Kadmon Holdings Inc
SANA / Sana Biotechnology, Inc.
ALPN / Alpine Immune Sciences, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
BLSA / BCLS Acquisition Corp - Class A
SIBN / SI-BONE, Inc.
SGEN / Seagen Inc
SRPT / Sarepta Therapeutics, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
NTLA / Intellia Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
LLY / Eli Lilly and Company
ARGX / argenx SE - Depositary Receipt (Common Stock)
BHC / Bausch Health Companies Inc.
APLS / Apellis Pharmaceuticals, Inc.
MLTX / MoonLake Immunotherapeutics
ONCS / OncoSec Medical Inc
PHAT / Phathom Pharmaceuticals, Inc.
SGRY / Surgery Partners, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CI / The Cigna Group
ATEC / Alphatec Holdings, Inc.
NTRA / Natera, Inc.
BPMC / Blueprint Medicines Corporation
BHVN / Biohaven Ltd.
BHVN / Biohaven Ltd. Call
ACET / Adicet Bio, Inc.
EPIX / ESSA Pharma Inc.
CTLT / Catalent, Inc.
GRTS / Gritstone bio, Inc.
NBIX / Neurocrine Biosciences, Inc.
ABBV / AbbVie Inc.
BBIO / BridgeBio Pharma, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
IDYA / IDEAYA Biosciences, Inc.
KROS / Keros Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
KZR / Kezar Life Sciences, Inc.
ISRG / Intuitive Surgical, Inc.
COGT / Cogent Biosciences, Inc.
SCYX / SCYNEXIS, Inc.
ARVN / Arvinas, Inc.